Oliviero, Elisabeth
Schmitz-Luhn, Björn
Mestre, Tiago A
Chandler, Jennifer A https://orcid.org/0000-0001-9471-4626
Funding for this research was provided by:
EU Joint Programme – Neurodegenerative Disease Research (HESOCARE-329-073)
Article History
Received: 25 August 2023
Accepted: 19 January 2024
First Online: 6 February 2024
Declarations
:
: EO and BSL have no disclosures. JAC sits on an Advisory Board to INBRAIN Neuroelectronics. TAM has received personal compensation for serving as a Consultant for CHDI, Sunovion, Roche, Biogen and nQ Medical. TAM has received personal compensation serving on a Speakers Bureau for Abbvie, Valeo Pharma and the International Parkinson and Movement Disorder Society.